SCHEMBL10128026

SCHEMBL10128026

Cc1ccc(-c2cn3c(-c4ccc(-c5cccc6c5sc5ccccc56)cc4)nnc3c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
RXFP1 Q9HBX9 2/20 0.41
MAPT P10636 4/20 0.40
TP53 P04637 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.39
PARP14 Q460N5 1/20 0.39
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
HTT P42858 1/20 0.37
PAX8 Q06710 1/20 0.37
PRKDC P78527 3/20 0.34
TSHR P16473 3/20 0.33
ALDH1A1 P00352 2/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128000 0.93 ALOX5 (0.45) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128013 0.92 ALOX5 (0.44) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10127977 0.91 ALOX5 (0.45) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128015 0.90 ALOX5 (0.43) ALOX5MAPTPARP14HTTPAX8
SCHEMBL10128025 0.89 ALOX5 (0.40) ALOX5RXFP1MAPTPOLBPARP14
SCHEMBL10128009 0.89 ALOX5 (0.43) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128028 0.88 ALOX5 (0.42) ALOX5RXFP1MAPTTP53POLB
SCHEMBL10128012 0.88 ALOX5 (0.46) ALOX5RXFP1MAPTTHRBPARP14
SCHEMBL10128010 0.88 ALOX5 (0.43) ALOX5MAPTPARP14HTTPAX8
SCHEMBL10128007 0.87 ALOX5 (0.46) ALOX5MAPTPARP14HTTPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 ALOX5 1457/4885RXFP1 3981/4885MAPT 1271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.